the 1.9-kb Pst I fragment of the murine cDNA clone mMP06"; p53,0.4-kb and 0.87-kb Pst I fragments of the murine cDNA clone pp53-176=; and scl, the 1.9-kb EcoRI fragment of the murine cDNA, corresponding to nucleotides 406 to 2335.% The origin of other probes is described el~ewhere.'~~~' Probes were labeled with [a-"PIdATP using a random hexamer priming kit (Bresatec Limited, Adelaide, South Australia).
Hematopoietic Assays
Conditioned medium collected from dense cell cultures was concentrated 10-fold in an ultrafiltration cell (model 8050; Amicon, Danvers, MA) and filtered before use. Granulocye-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) were assayed using FDC-PI cells (responsive to GM-CSF and IL-3) and 32D clone 23 cells (responsive to IL-3) as described previously." Erythropoietin (Epo) was assayed on fetal liver cells using day-2 colony-forming unit-erythroid (CFU-E) as a read0ut.2~ Levels of CSF were converted to bone marrow units'" by comparison with purified recombinant GM-CSF and IL-3 of known activity. Colonyforming cells were assayed by culturing cell lines at a range of concentrations in triplicate 1 mL agar cultures, with and without addition of indicated growth factors for 7 to 14 days at 37°C as described previously." Recombinant murine IL-3, GM-CSF, granulocyte-CSF (G-CSF), and leukemia inhibitory factor (LIF) were generously provided by Dr D. Metcalf, and recombinant human Epo by Dr A.W. Burgess.
Detection of Cell S u~a c e
Antigens Cells were stained with the monoclonal antibodies (MoAbs) M1/70 (aMac-l),SZ RB6-8C5 ('8C5'/aGr-l)," F4/80," and TER-119"; each had been directly conjugated to fluorescein isothiocyanate (FITC) or phycoerythrin (PE) (Southern Biotechnology Associates, Birmingham, AL), or biotinylated and revealed by an FITC-or PE-streptavidin second stage. All staining was performed in the presence of excess unlabeled anti-Fcy receptor antibody 2.4G2% to reduce nonspecific binding of antibodies, and cells were analyzed on a FACScan (Becton Dickinson, Sunnyvale, CA).
Cytochemical Stains
May-Grunwald-Giemsa, Lux01 Fast Blue, Astra Blue, and staining for a-naphthyl acetate esterase, myeloperoxidase, and acetylcholinesterase were performed on cytocentrifuge preparations or fixed agar colonies according to standard protocol^.^' Detection of the pseudoperoxidase activity of hemoglobin in agar colonies or cell suspensions was with benzidine HCl" or 2,7-diaminofl~orene.'~
RESULTS
Erythroid and mixed erythroid/mast cell hyperplasia was a frequent cause of morbidity in mice we reconstituted with bcr-abl virus-infected bone marrow cellsI9 (Elefanty and Cory, manuscript submitted). To further characterize this syndrome, we sought to establish cell lines by culturing the bone marrow and spleen cells of 19 mice in the absence of added growth factors. Twelve of the 15 lines that were derived (Table 1) were mast cell in origin; three grew rapidly from the outset but the majority grew very slowly, doubling every 2 to 7 days. The proviral insertion pattern shown by Southern blot analysis established that all but one of the cell lines were clonal and, in 9 of 10 cases, the pattern obtained from the cell line was identical to that obtained from the tissue of origin. Because six of the seven mast cell lines in this analysis derived from tissue infiltrated predominantly by erythroid cells, both populations probably descended from a common infected prec~rsor.'~ Six mast cell lines were maintained continuously in vitro for several months. Remarkably, they proved to be phenotypically unstable (Table 2) , most evolving towards erythroid/megakaryocytic differentiation. After cloning in agar, the phenotypic variants from all six lines were shown by proviral insertion analysis to derive from the same infected precursor as the initial mast cell line" (this report and unpublished results). The history of one erythroid/ megakaryocytic line (96.4) will be described in detail, as will that of an exceptional line (34.6) that became myeloid. The evolution of the bcr-ab1 lines towards a fully malignant phenotype will also be considered.
The 96.4 Line: A Switch From Mast Cell to Erythroid and Megakaryocytic Differentiation
Clonal phenotypic variants. Figure 1A summarizes the evolution of the 96.4 mast cell line, which was obtained from the spleen of a BALB/c mouse with erythroid, mast cell, and macrophage disease (Elefanty and Cory, manuscript submitted). The slow-growing line was independent of the exogenous IL-3 required by normal mast cells, but may have been provided with growth factors by the stromal component present during the first few weeks of culture. After about 3 months, a rapidly growing subline of mast cells (designated 96.43Mst) arose in one of several cultures grown in parallel. The cells in another flask of the slowgrowing line (designated 96.42Mst) underwent a dramatic change after another 2 months. Within 1 week, the culture became pleomorphic (compare Fig 1B with 1C and D) and cytospin preparations (Fig 1E and F) showed that the mast cells had been replaced by maturing erythroid cells and megakaryocytes that stained with acetylcholinesterase (not shown). Most cells (70%) in this subline (96.42EMeg) contained hemoglobin, as judged by staining with benzidine or diaminofluorene and over 50% reacted strongly with the erythroid-specific MoAb TER-119.35 After 2 months, one 96.42EMeg culture yielded a subline (96.42Ery) that retained erythroid character but exhibited few mature megakaryocytes.
Evidence that the mast cell, erythroid/megakaryocytic, and erythroid subclones all carried the same proviral insert as the original splenic tissue and hence derived from a single infected precursor was provided by Southern blot analysis for provirus-host DNA junction fragments in EcoRI digests (Fig 2A) and Hind111 digests (not shown). RNA analysis (Fig 2B) established that the bcr-ab1 gene was expressed and confirmed the lineage assignments of the cell lines. Expression of the a chain of the high-affinity IgE receptor'' and c-kit, the receptor for mast cell growth factor (MGF)? was detectable only in the mast cell lines (lanes 1 and 2), while p globin and Epo receptor expression was found only in sublines containing erythroid cells (lanes 3 and 4). Two genes encoding transcription factors implicated in erythroid differentiation, GATA-1 and scl/tal, were expressed in the mast, erythroid, and erythroid/ For personal use only. on November 11, 2017. by guest www.bloodjournal.org From IlRetroviral integration pattern of cell line determined by Southern blotting (see Fig 2A) to be identical (I) or different (D) to that of tissue of origin or, for mouse 34.8, of tumor deposits elsewhere in the primary mouse. ND, not done due to insufficient material; these four animals had oligoclonal tumors at other sites.
llA clonal T-lymphoid thymoma was present that derived from the same progenitor (mouse 33.2) or a different progenitor (mouse 34.8) to the macrophage or mast cell disea~e.'~ #Four of six recipients developed tumors following a long latency (6 months). vitro, but they were only cultured for 1 to 4 months. §These lines evolved from the erythroid/mast cell line.
IlAlthough mast cells dominated the primary cultures from these mice, some erythroblasts persisted from the outset.
BPreviously described," but the megakaryocytic component was not initially appreciated.
#Rare clones obtained after infection of the 52.5Mst line with a retrovirus expressing a mutated p53 cDNA; whether p53 played any role is obscure. showed that the three clones tested secreted low levels of IL-3 (1 to 5 U/mL) as well as GM-CSF (5 to 900 U/mL). All three erythroid/megakaryocytic and both erythroid subclones tested secreted GM-CSF (5 to 100 U/mL). A low level of Epo bioactivity (0.05 U/mL) was detected in the single erythroid clone tested, but not in an erythroid/megakaryocytic clone.
The range of differentiation stages detectable in the 96.42EMeg and 96.42Ery lines was impressive. Both produced macroscopic colonies of erythroblasts in the spleen of lethally irradiated syngeneic mice 12 to 14 days after injection. Spleen colony formation, a property displayed by some early stem cells (CFU-S), was not obtained with the other bcr-ab1 erythroid cell line (33.3Ery) tested. When cultured in semi-solid agar, the 96.42 erythroid lines yielded diverse colony types ( Table  3 ). The EMeg line produced large compact colonies containing blast cells (some colonies were white, others red due to a large erythroid component), as well as small single- (Fig 3) . In contrast, the Ery subline yielded fewcr megakaryocytic colonies and many more overtly hemoglobinized colonies (Table 3) . Only the white compact colonies retained a high proliferative potential upon replating (data not shown). Addition to the agar cultures of IL-3 or Epo (Table 3) or GM-CSF (not shown) affected neither the plating efficiency nor the distribution, size, or morphology of colonies.
The 96.4 line did not readily switch its differentiation pattem. Despite the phenotypic shift just described, the 96.4 primary mast cell line was not intrinsically unstable in vitro. After being maintained for 8 months in liquid culture, 96.42Mst cells could be cloned in agar, but only on onc occasion over the next 5 months were erythroid colonies detected amongst the mast cell colonies. These were established as EMeg lines that displayed the same proviral insert as all other 96.4 sublines (Fig 2A, lane 5) , but the liquid culture from which they derived was not overtaken by erythroid cells, perhaps because the mast cells themselves now grew more rapidly or because the second EMegvariant was not as competitive as the earlier one.
Because the demethylating agent 5-azacytidine has been shown to induce a lymphoid to macrophage switch in an Abelson-transformed ccll line,M we attempted to induce a mast to erythroid/megakaryoqtic switch by incubating three 96.42 Mst clones with up to 6 pmol/L 5-azacytidine for 1 to 5 days. As only one treated culture acquired a small number ( -12%) of benzidine-staining cells, we infer that the genetic change(s) required to permit erythroid/ megakaryocytic differentiation of the 96.42Mst progenitor cell is not readily induced by demethylation.
The 34.6 Line: A Switch From Mast Cell to Erythroid and Myeloid Differentiation
The 34.6 mast cell line (34.6Mst) was derived from the near-normal bone marrow of a C57BL/6 mouse with a modest hcr-ahl-induced erythroid and macrophage tumor burden." As outlined in Fig 4A, prolonged culture of this line produced both an erythroid and a myeloid variant. Once again, Southern blotting established that the subcloned phenotypic variants and the primary mast cell line derived from a single infected precursor (Fig 5A) . 1 and 2 in Fig 5B) "The 96.42EMeg cell line was assayed after 6 months and the tlL-3 was used at 1,000 UlmL and Epo at 1 UlmL. *Morphology after 7 days of culture; 150 to 500 colonies from 4 to 9 plates were scored per stimulus. The plating efficiency of 96.42EMeg ranged from 0.7% to 0.9% and of 96.42Ery from 0.4% to 1.3% for the different stimuli, and was linear over cell concentrations of lo' to 1O'lmL. Agar plates and individual colonies were stained with benzidine or for acetylcholinesterase to confirm erythroid and megakaryocytic elements, respectively. White compact colonies were composed of blast cells with small numbers of erythroblasts and megakaryocytes, while red compact colonies were dominated by erythroblasts with few blasts and megakaryocytes.
§Colonies containing megakaryocytes, either alone or mixed with erythroid cells.
I!Colonies with a diffuse morphology (Fig 3F) that contained erythroid and megakaryocytic cells. and previously thought to be macrophage although other features suggestive of macrophage diffcrcntiation were not present. Attempts to differentiate 34.6Ery.3 cells with 1.5% DMSO in liquid culture showed marked toxicity, but the surviving cells acquired some cytoplasmic granules suggestive of reversion to a mast cell phenotype.
After 2 months in vitro, the mast cell culture generated from the spleen of a mouse transplanted with 34.6EMst cells was monopolized by maturing myeloid cells that grew in tight clumps (Fig 4F) , unlike the crythroid/mast ccll or its erythroid derivative (Fig 4E) . The line was cloned in agar and designated A shft to myeloid differentiation. cytic cells (Fig 4G) that stained strongly for myeloperoxidase (Fig 4H) . Depending on the clone, 5% to 80% of the cells were cosinophils and their precursors, because Lux01 Fast Blue showed small numbers of emerald green cytoplasmic granules. Less than 5% of the cells were phagocytic adherent macrophages but -30% expressed a-naphthyl acetate esterase. RNA analysis showed myeloperoxidase transcripts in 34.6Myl but no detectable mRNA for p globin or the IgE receptor (Fig 5B, lane 3) .
34.6MyI cells formed granulocyte-macrophage colonies in agar in the absence of added growth factors. Neither plating efficiency nor colony morphology was affected by the inclusion of IL-3, GM-CSF, G-CSF, M-CSF, Epo, or LIF in the assays (not shown). However, analysis of 34.6Myl. All 12 clones analyzed were dominated by granuloconditioned medium showed endogenous production of GM-CSF (up to 1,400 U/mL) and IL-3 (up to 100 U/mL). In contrast, minimal levels of GM-CSF were detected in the 34.6 mast and erythroid phenotypic variants.
Granulocytic differentiation of 34.6Myl cells was enhanced by DMSO and sodium butyrate (Fig 41) , and 16 nmol/L tetradecanoyl phorbol acetate increased the number of adherent phagocytic macrophages in some clones (Fig 45) . DMSO increased Mac-1 expression and most cells (>90%) acquired F4/80, while a subpopulation (5% to 15%) also expressed the 8C5 mature granulocytic marker (data not shown). Granulocytic differentiation was associated with downregulation of myeloperoxidase, as assessed by RNA analysis (Fig SB, lanes 3 through 6) and cytochemical staining (not shown), and also with considerable GM-CSF mRNA induction (Fig 5B) .
Evolution of the Transformed Phenotype
The slowly growing mast cell lines were not malignant (Table 4 ) and, with one exception, were derived from animals in which the primary disease, although lethal, was not transplantable (Table 1) . Furthermore, although at 18 weeks the still slowly growing 96.42Mst culture contained transplantable cells, the tumor latency was very long (37 weeks) and only after 29 weeks in culture were clonogenic cells detectable in agar. These observations suggest that although bcr-ab1 expression confers a growth advantage in vivo and in vitro, further somatic mutation(s) must accrue to achieve complete transformation. Those cell lines (erythroid or mast) that were transplantable from the outset ( Table 4 ), and that derived from transplantable primary tumors (Table l) , had presumably already acquired secondary mutation(s) in vivo.
Because the tumor suppressor gene p53 is mutated in many CML patients in blast crisis:d7 we investigated p53 expression in bcr-ab1 lines that had become malignant. Diminished expression of p53 may have contributed to the malignancy of the 33.3Ery line, because p53 RNA levels were much lower in this line, especially after prolonged culture (Fig 6C, lanes 13 and 14) , than in other erythroid lines (Fig 6, lanes 3, 4, 6 , 12, 15, and 16). Levels were also low in the myeloid derivative of 34.6 ( Fig 6B) and in three of the four mast cell lines examined (Fig 6, lanes 1,2, and 10) . Sequence analysis will be required to fully assess the role of p53, because oncogenic changes affecting p53 function frequently involve point mutations" and thus may not be detectable by Northern analysis.
The ets-related transcription factor PU.1, expressed in macrophage and B-lymphoid c e l l s , @ ' corresponds to a gene previously designated Spi-1 or Sfpi-1 that is silent in normal erythroid cells but frequently activated by proviral insertion in Friend erythroleukemia.m Sfpi-1 expression was readily detectable in several of the erythroid lines (Fig 6, lanes 6,  12,13 , and 15) and may therefore have played a role in their neoplastic progression. Other bcr-ab1 erythroid lines, however, lacked Sfii-1 expression (Fig 6, lanes 3,4, and 16 ).
Differentiation Capacity of the Cell Lines In vivo
Histologic analysis of animals transplanted with the established cell lines permitted assessment of their differentiation capacity in vivo ( Table 4) . Mice injected with 96.42EMeg cells developed erythroleukemia with greatly elevated numbers of circulating erythroblasts (Fig 1G) . Although both 96.42Mst and 96.43Mst cells produced disseminated mast cell tumors, all four animals examined also contained areas of erythroid tumor in the spleen. This finding may indicate that the cells had a wider differentiation potential in vivo than in vitro, or that the frequency of 'lineage switch' mutations was relatively high in vivo. Within the 34.6 series, the 34.6Myl.l clonc produced disseminated myelomonocytic tumors, while all six recipients of 34.6EMst cells succumbed to various combinations of erythroid, mast cell, and macrophage tumors. Unexpectedly, the tumors arising after injcction of the relatively undifferentiated erythroid clone 34.6Ery.3 were mast cells, implying that its differentiation potential had also been modified by environmental signals or by mutation.
DISCUSSION
The bcr-abl-expressing mast cell lines characterized here were obtained from mice that had developed erythroid and/or mast cell hyperplasia after lethal irradiation and (14) 33.3Ery.2 (11 months), (15) 34.4EMeg (7 months), and (16) 55.3Ery (2 weeks).
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From reconstitution with hcr-ah1 virus-infected bone marrow" (Elcfanty and Cory, manuscript submitted). The virusinfected cell responsible for the syndrome appears to have been a progenitor cell with capacity for both mast cell and erythroid differentiation, as judged by clonal analysis of affected tissues and derived cell lines (Elcfanty et all" and this report). The hcr-ah1 mast cell lines grew in the absence of exogenous IL-3, unlike normal mast cells, but initially may have required factors produced by associated stromal cells, eg, the recently identified MGF or Steel factor. They produced significant levels of GM-CSF and IL-3. When first established, most lines were neither transplantable nor clonogenic in soft agar, but transplantable cells emerged after prolonged culture, prcsumably due to additional (undefined) oncogenic mutations. Analogous factor-indcpendent mast cell lines produced by Abelson virus infection of multilineage or blast cell colonies"." or 18-day fetal liver cells" also secreted multiple growth factors"." and initially required stromal cell support,"." but became fully malignant much more rapidly than the hcr-ah1 lines (2 to 3 months after virus infcction v 6 to 20 months). This finding probably reflects differences in the transforming potency of v-uhl and p210 hcr-ah1 proteins.
The striking feature of the hcr-ah1 cell lines was their propensity to spontaneously change hematopoietic lineage on prolonged culture, a property never previously documented for mast cell lines. Several assumed an erythroid or erythroid/megakaryocytic character, but one became myeloid (Table 2) . In each case, the variant line contained the same proviral insert as the parental mast cell line (Fig 2A  and SA and data not shown) .
Several of the variant sublines exhibited a marked capacity to continuously differentiate, despite being highly malignant. The 96.4EMeg line and its subclones, for example, yielded mature erythrocytes and megakaryocytes in the absence of added growth factors (Fig 1) . Because normal erythroid differentiation requires Epo and/or IL-3, and Epo was detected in the conditioned medium of one hcr-ah1 erythroid clone, an autocrine loop may have figured in their evolution. Intriguingly, spontaneous hemoglobinization is a feature of some erythroid progenitors in the chronic phase of CML.'6 A surprisingly high proportion (5 of 13) of the cell lines established from CML blast crisis patients (eg, K562) exhibit some erythroid and/or megakaryocytic character, but induction by chemical agents is usually required to promote differentiation."' Equivalent lines have not been isolated with Abelson virus; differentiating erythroid colonies isolated from infected fctal liver cells could not be established in culture."
The differentiation capacity of the hcr-ah1 myeloid line (34.6Myl) strongly resembled that of the well-studied promyelocytic line HL-60 derived from a patient with acute myeloid leukemia.'" Both differentiate spontaneously along neutrophil, eosinophil, and macrophage lines, the degree of differentiation being enhanced by a range of chemical inducers. 34.6Myl cells secrete GM-CSF and IL-3 and an 'autocrinc activity' has been observed in H L d k o n d itioned medium.5N None of the existing CML lines shows such a degree of myeloid differentiation and no equivalent lines have been isolated with Abelson virus. However, one clone of the IL-3-dcpcndcnt line 32D, which was initially characterized as a mast cell line,'" has the capacity to terminally differentiate into granulocytes if IL-3 is replaced by G-CSF." ' The nature of the cells involved in the 'lineage switches' is an intriguing, although unresolved, issue. Figure 7 depicts our current working hypothesis It seems unlikely that mature mast cells are capable of the phenotypic shifts observed, so we presume that the affected cells were precursors present at low concentration in the cultures. These cells may have been committed, unipotential mast cell progenitors or oligopotential cells unable to express their full potential under the growth conditions provided. (The observation that certain lines exhibited a wider differentiation potential in vivo than in vitro may favor the latter hypothesis.) In either case, phenotypic switching in vitro prcsumably resulted from somatic mutation(s) that either provided necessary growth factor(s) or induced key transcriptional programming gene(s). Our failure to mimic such mutation by treatment with 5-azacytidinc suggests that the mechanism of the lineage switch is more complex than activation of a single gene by demethylation.
For 96.42, the switch from mast to erythroid/megakaryocytic differentiation was accompanied by transformation, raising the possibility that the same gene(s) orchestrated both events. Many of the genes encoding nuclear oncoprotcins (which might cooperate with cytoplasmic hcr-ahl) are known to be transcription factors and might well influence the differentiation program. However, transformation and phenotypic change were not always linked. The myeloid switch in the 34.6 line, for example, occurred in a cell that was already tumorigenic and clonable in agar.
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Erythroid/megakaryocytic Myeloid differentiation differentiation For personal use only. on November 11, 2017. by guest www.bloodjournal.org From vides clues to the function of bcr-ab1 and its role in CML. Expression of bcr-ab1 by a hematopoietic progenitor and its progeny provides only a modest proliferative advantage and relieves certain growth factor requirements but probably not ail. Whether growth factor production, particularly of IL-3,I3 is crucial to the action of bcr-ab1 (and v-abl) or is merely an epiphenomenon remains an important unresolved issue. The unexpected phenotypic plasticity of the cell lines suggests that bcr-ab1 expression may facilitate and/or complement the (postulated) somatic mutations in lineage-determining genes. Finally, our observation that even fully transformed lines can retain substantial capacity for maturation suggests that the chronic phase of CML may accumulate mutations that increase malignancy without significantly curtailing differentiation. Thus, more events may be needed to progress to blast crisis than hitherto suspected. The lines characterized here may facilitate identification not only of genes able to cooperate with bcr-ab1 in leukemogenesis but also those instrumental in determining lineage commitment during normal hematopoiesis.
